Abstract
Background
Several surgical adverse events (SAEs) have been associated with Deep Brain Stimulation (DBS) of the subthalamic nucleus (STN) in Parkinson’s Disease (PD) patients, leading to certain confusion about the risk/benefit ratio of this technique, and giving rise to the need of more and more extensive control studies over longer periods. The aim of this article is to identify and quantify the factors associated with the most frequent AEs from STN DBS in PD-diagnosed patients.
Methods
The following variables were studied: aborted procedure, misplaced leads, intracranial haemorrhage, and seizures. This study was carried out in 233 patients diagnosed with PD, with 455 STN electrodes implanted and follow-up after 7 (8–14) years follow up.
Results
A total amount of 56 SAEs occurred in 49 patients (11.76 % of total procedures, 12.31 % of implanted leads, 21.03 % of patients). SAEs were: five aborted procedures, 26 misplaced leads, ten intracranial haemorrhages, and 15 seizures. Of all the SAEs, long-term effects only happened in two cases of hemiparesis caused by intracranial haemorrhage; the other SAEs were reversible and didn’t leave any long-term clinical consequences (0.42 % of procedures, 0.44 % of leads, and 0.86 % of patients).
Conclusions
STN DBS in PD patients is a safe surgical procedure, with good risk/benefit ratios: procedure reliability/correct lead implantation in 95.59 %, 0 mortality/implanted lead, 0.12 morbidity/implanted lead, and 0.0043 neurological sequelae/implanted lead.
Similar content being viewed by others
References
Baizabal JF, Simpson R, Jankovic J (2011) Diagnosis and treatment complications related to deep brain stimulation hardware. Mov Disord 28:1398–1406
Bakay RAE, Daniluk S, Davies KG, Novak P, Vu T, Nazzaro JM, Ellias SA (2009) Isolation of the brain-related factor of the error between intended and achieved position of deep brain stimulation electrodes implanted into the subthalamic nucleus for the treatment of Parkinson’s disease. Neurosurgery 64(ONS Suppl 2):374–384
Benabid AL, Binder DK, Rau GM, Starr PA (2005) Risk factors for haemorrhage during microelectrode-guide deep brain stimulator implantation for movement disorders. Neurosurgery 56:722–732
Benabid AL, Chabardes S, Mitrofanis J, Pollak P (2009) Deep brain stimulation of the subthalamic nucleus for the treatment of Parkinson’s disease. Lancet Neurol 8:67–81
Ben-Haim S, Asaad WF, Gale JT, Eskandar EN (2009) Risk factors for haemorrhage during microelectrode-guided deep brain stimulation and the introduction of an improved microelectrode design. Neurosurgery 64:754–763
Binder DK, Rau GM, Starr PA (2005) Risk factors for haemorrhage during microelectrode-guide deep brain stimulator implantation for movement disorders. Neurosurgery 56:722–732
Boviatsis E, Stavrinou L, Themistocleous M, Kouyialis A, Sakas D (2010) Surgical and hardware complications of deep brain stimulation. A seven-year experience and review of the literature. Acta Neurochir 152:2053–2062
Bronstein JM, Tagliati M, Alterman RL, Lozano AM, Volkmann J, Stefani A, Horak FB, Okun MS, Foote KD, Krack P, Pahwa R, Henderson JM, Hariz MI, Bakay RI, Rezai A, Marks WJ, Moro E, Vitek JL, Weaver FM, Gross RE, DeLong MR (2011) Deep brain stimulation for Parkinson’s disease. An expert consensus and review of key issues. Arch Neurol 68:165–171
Burdik A, Fernández H, Okum M, Chi Y, Jacobson C, Foote K (2010) Relationship between higher rates of adverse events in deep brain stimulation using standardised prospective recording and patient outcomes. Neurosurg Focus 29(2):E4
Chabra V, Sung E, Mewes K, Bakay RA Abosch A, Gross RE (2010) Safety of magnetic resonance imaging of deep brain simulator systems: a serial imaging and clinical retrospective study. Clinical article. J Neurosurg 112:497–502
Chan DTM, Zhu XL, Yeung JHM, Mok VCT, Wong E, Lau C, Wong R, Lau C, Poon WS (2009) Complications of deep brain stimulation: a collective review. Asian J Surg 32:258–263
Coley E, Farhadi R, Lewis S, Whittle IR (2009) The incidence of seizures following deep brain stimulating electrode implantation for movement disorders, pain and psychiatric conditions. Br J Neurosurg 23:179–183
Daniluk S, Davies KG, Novak P, Vu T, Nazzaro JM, Ellias SA (2009) Isolation of the brain-related factor of the error between intended and achieved position of deep brain stimulation electrodes implanted into the subthalamic nucleus for the treatment of Parkinson’s disease. Neurosurgery 64(ONS Suppl 2):374–384
Doshi P (2011) Long-term surgical and hardware-related complications of deep brain stimulation. Stereotact Funct Neurosurg 89:89–95
Elias WJ, Fu K-M, Frysinger RC (2007) Cortical and subcortical brain shift during stereotactic procedures. J Neurosurg 107:983–988
Elias WJ, Sansur CA, Frysinger RC (2009) Sulcal and ventricular trajectories in stereotactic surgery. J Neurosurg 110:201–207
Fahn S, Elton RL, the members of the Unified Parkinson’s disease Rating Scale (1987) Recent developments in Parkinson’s disease. Vol 2. Florham Park NJ. In: Fahn S, Marsden CD, Calne CB, Goldstein M (eds) MacMillan healthcare information., pp 153–163
Falowski S, Ooi YC, Smith A, Metman LV, Bakay RAE (2012) An evaluation of hardware and surgical complications with deep brain stimulation based on diagnosis and lead location. Stereotact Funct Neurosurg 90:173–180
Follet KA, Weaver FM, Stern M, Hur K, Harris CL, Luo P, Marks WJ, Rothlind J, Sagher O, Moy C, Pahwa R, Burchiel K, Hogarth P, Lai EC, Duda JE, Holloway K, SAmii A, Horn S, Bronsteins JM, Stoner G, Starr PA, Simpson R, Baltuch G, De Salles A, Huang GD, REda DJ, CSP 468 Study Group (2011) Pallidal versus subthalamic deep-brain stimulation for Parkinson’s disease. N Engl J Med 362:2077–2091
Gologorsky Y, Ben-Haim S, Moshier E, Godbold J, Tagliati M, Weisz D, Alterman R (2011) Transgressing the ventricular wall during subthalamic deep brain stimulation surgery for Parkinson’s Disease increases the risk of adverse neurological sequelae. Neurosurgery 69:294–300
Goodman RR, Kim B, McClelland S III, Senatus PB, Winfield LM, Pullman SL, Yu Q, Ford B, McKhann GM (2006) Operative techniques and morbidity with subthalamic nucleus deep brain stimulation in 100 consecutive patients with advanced Parkinson’s disease. J Neurol Neurosurg Psychiatry 77:12–17
Krack P, Batir A, Van Blercom N, Chabardes S, Fraix V, Ardouin C, Koudsie A, Limousin PD, Benazzouz A, Le Bas JF, Benabid AL, Pollak P (2003) Five-year follow up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson’s disease. N Engl J Med 349:1925–1934
Hu X, Jiang X, Zhou X, Liang J, Wang L, Cao Y, Liu J, Jin A, Yang P (2010) Avoidance and management of surgical and hardware-related complications of deep brain stimulation. Stereotact Funct Neurosurg 88:296–303
Lang AE, Widner H (2002) Deep brain stimulation for Parkinson’s disease: patient selection and evaluation. Mov Disord 7:94–101
Langston JW, Gotees CG, Brooks D, Fahn S, Freeman T, Watts R (1992) Core assessment program for intracerebral transplantations. Mov Disord 7:2–13
Limousin P, Pollak P, Benazzouz A, Hoffmann D, Le Bas JF, Broussolle E, Perret JE, Benabid AL (1995) Effect on parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation. Lancet 345:91–95
Lyons KE, Wilkinson SB, Overman H, Pahwa R (2004) Surgical and hardware complications of subthalamic stimulation. A series of 160 procedures. Neurology 63:612–616
Miyagi Y, Shima F, Sasaki T (2007) Brain shift: an error factor during implantation of deep brain stimulation electrodes. J Neurosurg 107:989–997
Oh MY, Abosch A, Kim SH, Lang A, Lozano A (2002) Long-term hardware-related complications of deep brain stimulation. Neurosurgery 50:1268–1276
Okun MS, Tagliati M, Pourfar M, Fernández HH, Rodríguez RL, Alterman RL, Foote KD (2005) Management of referred deep brain stimulation failures; a retrospective analysis from 2 movement disorders centres. Arch Neurol 62:1250–1255
Patel NK, Plaha P, Gill SS (2007) Magnetic resonance imaging-directed method for functional neurosurgery using implantable guide tubes. Neurosurgery 261:358–366
Patel NK, Khan S, Gill SS (2008) Comparison of atlas and magnetic-resonance-imaging based stereotactic targeting of the subthalamic nucleus in the surgical treatment of Parkinson’s disease. 86:153–161
Pouratian N, Reames DL, Frysinger R, Elias WJ (2011) Comprehensive analysis of risk factors for seizures after deep brain stimulation surgery. J Neurosurg 115:310–315
Rodríguez-Oroz MC, Obeso JA, Lang AE, Houeto JL, Pollak P, Rehncrona S, Kulisevsky J, Albanese A, Vokmann J, Hariz MI, Quinn NP, Speelman JK, Guridi J, Zamarbide I, Gironell A, Mollet J, Pascual-Sedano B, Pidoux B, Bonnet AM, Agid Y, Xie J, Benabid AL, Lozano AM, Saint-Cyr J, Romito L, Contarino MF, Scerrati M, Fraix V, Van Blercom N (2005) Bilateral deep brain stimulation in Parkinson’s disease: a multicentre study with 4 years follow-up. Brain 128:2240–2249
Sansur Ch A, Frysinger RC, Pouratian N, Fu K-M, Bittl M, Oskouian RJ, Laws E, Elias J (2007) Incidence of symptomatic haemorrhage after stereotactic electrode placement. J Neurosurg 107:998–1003
Seijo F, Alvarez-Vega MA, Gutierrez JC, Fernández F, Lozano B (2007) Complications in subthalamic nucleus stimulation surgery for treatment of Parkinson’s disease. Review of 272 procedures. Acta Neurochir (Wien) 149:867–876
Seijo F, Lozano B, Santamarta E, Fernández F, Sainz A (2009) In deep brain stimulation: applications, complications and side effects. In: Rogers MH, Anderson PB (eds) Common questions and answers to deep brain stimulation surgery. Nova Science Publishers, Inc, New York, pp 1–29, ISBN: 978-1-60692-895-0
Tasker RR (1998) Deep brain stimulation is preferable to thalamotomy for tremor suppression. Surg Neurol 49:145–154
Vergani F, Landi A, Pirillo D, Cilia R, Antonini A, Sganzerla E (2010) Surgical, medical, and hardware adverse events in a series of 141 patients undergoing subthalamic deep brain stimulation for Parkinson’s disease. World Neurosurg 4:338–344
Videnovic A, Metmann LV (2008) Deep brain stimulation for Parkinson’s disease: prevalence of adverse events and the need for standardised reporting. Mov Disord 15:343–349
Voges J, Waerzeggers Y, Maarouf M, Lehrke R, Koulousakis A, Lenartz D, Sturm V (2006) Deep-brain stimulation: long-term analysis of complications caused by hardware and surgery-experiences from a single centre. J Neurol Neurosurg Psychiatry 77:868–872
Weaver FM, Follett K, Stern M, Hur K, Harris C, Marks WJ, Rothling J, Sagher O, REda D, MOy CS, Pahwa R, Burchiel K, Hogarth P, Lai EC, Duda JE, Holloway K, Samii A, Horn S, Bronstein J, Stoner G, Heemskerk J, Huang GD (2009) Bilateral deep brain stimulation vs. Best medical therapy for patients with advanced Parkinson’s disease: a randomised controlled trial. JAMA 301:63–73
Zrinzo L, Foltynie MR, Limousin P, Hariz M (2012) Reducing hemorrhagic complications in functional neurosurgery: a large case series and systematic literature review. J Neurosurg 116:84–94
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Additional information
Comments
Complications following Deep brain stimulation (DBS) surgery are relatively common and are generally either procedural related or hardware related.
Procedura; complications such as ICH, electrode misplacement, aborted procedures etc are closely related with the overall volume of cases done and have a clear relation with the single surgeon learning curve. Procedural complications are less common in high volume centre where there is a well-established DBS program; the authors clearly stated this point in their discussion. Is there a minimal volume of DBS procedure per year that make a centre safe on the procedural point of view ? In the UK a minimum of 10 DBS per year has been considered the cut off number to receive accreditation, I still consider this number too low, possibly 35-50 DBS procedures are the number that a DBS centre should be performing to minimize procedural risks.
Another important issue is infection in DBS which can be either associated with the implantation or with the hardware revisions.
Reduction of infections could be achieved with antibiotics impregnated hardware (as has been developed for shunt hardware) and close collaboration with the manufacture is necessary to improve the infection profile of DBS.
In this interesting paper the authors reported a relatively high rate of ICH, is this possibly associated with MER and multiple trajectories. The jury is still out regarding the necessity of MER but there is definitively an increased risk with this technique. Delayed ICH/strokes are potentially devastating complications and as for brain biopsies can occur in DBS, early post-operative CT may give a false sense of security.
The functional neurosurgical community should work harder to reduce the rate of complications both procedural and hardware related, in the future national and international registry will allow to identify potential solvable problems in DBS surgery.
References
Risks of common complications in deep brain stimulation surgery: management and avoidance.
Fenoy AJ, Simpson RK Jr. J Neurosurg. 2014 Jan;120(1):132-9.
Deep brain stimulation of the subthalamic nucleus in Parkinson's disease: surgical technique, tips, tricks and complications.
Kocabicak E, Temel Y. Clin Neurol Neurosurg. 2013 Nov;115(11):2318-23.
Cerebral venous infarction: a potentially avoidable complication of deep brain stimulation surgery.
Morishita T, Okun MS, Burdick A, Jacobson CE 4th, Foote KD. Neuromodulation. 2013 Sep;16(5):407-13.
One-step tunneling of DBS extensions--a technical note. Linhares P, Carvalho B, Vaz R. Acta Neurochir (Wien). 2013 May;155(5):837-40;
Deep brain stimulation hardware complications in patients with movement disorders: risk factors and clinical correlations.
Baizabal Carvallo JF, Mostile G, Almaguer M, Davidson A, Simpson R, Jankovic J. Stereotact Funct Neurosurg. 2012;90(5):300-6
Jibril Osman Farah
Liverpool, UK
Rights and permissions
About this article
Cite this article
Seijo, F., Alvarez de Eulate Beramendi, S., Santamarta Liébana, E. et al. Surgical adverse events of deep brain stimulation in the subthalamic nucleus of patients with Parkinson’s disease. The learning curve and the pitfalls. Acta Neurochir 156, 1505–1512 (2014). https://doi.org/10.1007/s00701-014-2082-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00701-014-2082-0